Gene: MAP4K3
Official Full Name: mitogen-activated protein kinase kinase kinase kinase 3provided by HGNC
Gene Summary: This gene encodes a member of the mitogen-activated protein kinase kinase kinase kinase family. The encoded protein activates key effectors in cell signalling, among them c-Jun. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10666 | MAP4K3 Knockout cell line (HeLa) | Human | MAP4K3 | 1:3~1:6 | Negative | Online Inquiry |
KO10667 | MAP4K3 Knockout cell line (HCT 116) | Human | MAP4K3 | 1:2~1:4 | Negative | Online Inquiry |
KO10668 | MAP4K3 Knockout cell line (HEK293) | Human | MAP4K3 | 1:3~1:6 | Negative | Online Inquiry |
KO10669 | MAP4K3 Knockout cell line (A549) | Human | MAP4K3 | 1:3~1:4 | Negative | Online Inquiry |
MAP4K3 Gene Knockout Cell Lines are specially engineered mammalian cell lines in which the MAP4K3 gene has been deliberately inactivated or “knocked out.” This specific gene plays a pivotal role in various signaling pathways that are crucial for cell proliferation, survival, and migration. By utilizing these knockout cell lines, researchers have the unique opportunity to investigate the biological functions and downstream effects of MAP4K3 loss, enabling a deeper understanding of its involvement in disease progression, including cancer and inflammatory diseases.
The key function of MAP4K3 involves its role as a mitogen-activated protein kinase kinase kinase (MAP3K), which initiates a cascaded signal transduction that leads to the activation of various MAPK signaling pathways. By utilizing MAP4K3 gene knockout cell lines, scientists can observe the resulting phenotypic changes that occur due to the absence of this critical kinase, providing invaluable insights into cellular responses under different experimental conditions, such as stress or pharmacological treatments.
In research and clinical settings, these knockout cell lines are instrumental in elucidating mechanisms of drug resistance, identifying potential therapeutic targets, and developing novel treatment strategies. Their relevance increases in studies investigating the tumor microenvironment, where understanding the role of individual genes can lead to tailored therapeutic interventions.
Compared to traditional cell lines, where the MAP4K3 gene remains intact, MAP4K3 Gene Knockout Cell Lines offer a clear advantage by providing a controlled environment to study specific genetic contributions without confounding effects. These specialized lines have undergone rigorous validation to confirm the knock out efficiency, ensuring reliable and reproducible results.
For researchers and clinicians focusing on molecular genetics, cancer biology, and drug discovery, the value of MAP4K3 Gene Knockout Cell Lines is underscored by their ability to provide precise data that can drive forward scientific knowledge and innovation.
Our company specializes in developing high-quality biological products, ensuring each cell line is produced under stringent quality control standards to meet the evolving needs of the scientific community. By investing in our MAP4K3 Gene Knockout Cell Lines, you are equipping yourself with powerful tools for advancing your research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.